相关实验视频
Updated: Jun 17, 2025
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.6K
抑制补充因子C5a或C5aR,用于与胆固醇晶体栓塞相关的血管血栓与微血管损伤及其后果
Danyang Zhao1, Chao Han2, Elmina Mammadova-Bach2
1Department of Medicine IV, Hospital of Ludwig-Maximilian-University, Munich, Germany.
Kidney international
|August 14, 2024
概括
准C5a/C5aR通路可以防止由胆固醇晶体栓塞 (CCE) 引起的损伤和器官衰竭. 阻断C5a或C5aR有效治疗已建立的CCE,为高风险患者提供潜在的治疗策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 胆固醇晶体栓塞 (CCE) 导致免疫血栓,组织亡和器官衰竭.
- 目前没有针对CCE的特定治疗方法.
- CCE涉及补体系统的激活,暗示潜在的治疗点.
研究的目的:
- 研究C5a/C5aR轴抑制剂在减轻CCE后果方面的疗效.
- 探索C5a/C5aR阻塞作为CCE的潜在治疗方法.
主要方法:
- 在野生型小鼠中通过将胆固醇微晶注射到动脉中诱导CCE.
- 评估免疫血栓形成,膜过率 (GFR) 和亡.
- 对基因缺陷 (C3或C5aR) 和药理阻塞 (C5a或C5aR抑制剂) 对CCE结果的评估.
主要成果:
- 胆固醇微晶注射引发了快速的内免疫血栓形成和随后的损伤.
- 遗传缺陷或C3或C5aR的阻断可以防止免疫血栓形成和亡.
- 延迟的C5a封锁有效地解决了现有的血块,并防止了CCE相关的损伤.
结论:
- 选择性阻断C5a或C5aR足以减轻已建立的CCE的影响.
- 抑制C5a/C5aR是一种可行且安全的治疗策略,用于高风险的CCE患者.
更多相关视频
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
01:16Clot Retraction and Fibrinolysis
5.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.0K